Driving Innovation and Consistency in ALS Trials: Collaborative Models, New Outcomes, and Smarter Study Design
- Elevating trial quality through harmonized SOP‑based training across 60 European sites.
- Advancing TRICALS outcome measures and prediction models to include broader patient populations.
- Strengthening industry–academic collaboration to streamline innovation without duplicating efforts.
- Key insights from annual pharma masterclasses on emerging challenges in ALS trial design.